Tele: 561.316.3330
Breaking Medical Device News

Thursday, September 23, 2021
HomeVivos Therapeutics Inc.Vivos Therapeutics Successfully Launches Online Training to Healthcare Professionals During Pandemic

Vivos Therapeutics Successfully Launches Online Training to Healthcare Professionals During Pandemic

Today Vivos Therapeutics, Inc., a company focused on addressing the root causes of mild-to-moderate obstructive sleep apnea (OSA), has announced the recent launch and has seen a significant surge in demand for, its online education and training program, which enables dentists and other healthcare providers around the U.S. to learn about the emerging field of craniofacial sleep medicine.

Vivos Therapeutics believes it offers the single-biggest breakthrough in OSA treatment since CPAP. Vivos’ proprietary system has been shown to enhance and open the upper airway, significantly lower Apnea Hypopnea Index (AHI) scores and improve other conditions associated with OSA, offering patients what is believed to be the first effective, non-surgical, non-invasive and potentially lasting solution for OSA. Moreover, clinical results are typically achieved rather quickly (in about 12 to 24 months or less), at a relatively low cost, and without the need for lifetime intervention, unlike CPAP or other oral appliances.

Vivos sponsored its first online education and training Summit on March 26-27, featuring selected clinicians from the dental and medical arena, reaching maximum capacity in just three days, with over 500 dentists in attendance. Six additional two-day encore events were quickly scheduled twice a week thereafter to accommodate the surging demand, with some reaching maximum capacity in mere hours after posting on the event website. Currently, over 4,300 healthcare professionals concerned about sleep, breathing, and wellness have registered for this novel and powerful program.

“We believe our approach represents the world’s first hope for a potentially global solution to the estimated one billion who suffer from OSA, which is a serious and growing health epidemic,” says R. Kirk Huntsman, co-founder, and CEO at Vivos. “By going virtual with sleep/breathing education and training, we have created an opportunity for everyone to come and learn about the latest developments in currently available treatment options.

“The world is experiencing unprecedented times with respiratory diseases, and we believe our approach and related services could make a huge difference in the lives of many,” continued Huntsman. “The demand for learning more about sleep-disordered breathing has been overwhelming, as dentists and other professionals learn how to incorporate craniofacial sleep medicine into their practices once the COVID-19 pandemic is over.”

Vivos’ approach is comprised of specially designed, customized appliances integrated into a patient-specific, multi-disciplinary clinical protocol that is used by trained dental and medical providers to address certain craniofacial conditions associated with sleep-disordered breathing, including OSA, pioneered by the work of Vivos Therapeutics founder Dr. Dave Singh.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

Kleiner Device Labs Receives FDA Market Clearance for KG2 Surge Flow-Thru Interbody System

The system maximizes total bone graft delivery volume, better distributes graft bilaterally into the intervertebral disc space, and streamlines the implant delivery, positioning, and grafting process for TLIF and PLIF spinal fusion procedures.

Matthew Cranfill New ExtriCARE USA Director Of Clinical Services

"Matt's impressive experience and skillset easily made him our top pick," said Peter Mason, President of ExtriCARE USA.

FDA Authorizes Software that Can Help Identify Prostate Cancer

The software is called Paige Prostate and is compatible for use with slide images that have been digitized using a scanner.

Shannon Lantzy MedCrypt New VP of Consulting

"I met Shannon at a healthcare-related event several years ago and was immediately impressed with her passion and drive to move healthcare into a digital future," said Mike Kijewski, CEO of MedCrypt.

Mark Foster Joins Xenocor BOD

Foster is a versatile and visionary C-Suite executive who brings 20 years of general management and leadership experience from both venture-backed growth-stage organizations and world-class medical device companies

Hinge Health Acquires the Most Advanced Computer Vision Technology for Tracking Human Motion

CEO Daniel Perez explained, “We won’t stop investing in technology to deliver the most patient-centered digital clinic that improves member experience and outcomes while reducing costs. wrnch allows us to take a giant leap forward in all respects.”

Dale W Wood Congratulates the Huma Team on Raising $130 Million

Major health and technology companies across the world have committed upwards of $130 million to Huma Therapeutics, the health-tech company backed by Dale Ventures.

Rhaeos Awarded $4 Million NIH SBIR Grant

Under the NIH SBIR grant, Rhaeos will leverage their existing wireless sensor hardware to provide additional quantitative flow data to the clinician, giving insight into this currently inaccessible and highly relevant shunt performance metric.

By using this website you agree to accept Medical Device News Magazine Privacy Policy